Browsing: 0471

Weight Loss

Anatara Lifesciences Reports $0.471 Million Cash Position as AOC Anti-Obesity Compound Shows Statistically Significant Results

By 0

Anatara Lifesciences Ltd (ASX:ANR) reported cash of $0.471 million at the end of the June 2026 quarter, down from $0.707 million at 31 March, alongside pre-clinical results showing its anti-obesity candidate compound “AOC” produced two independent measures of statistically significant activity in managing weight regain. The company is now reviewing designs for a possible open…